share_log

'Sea Change': Irwin Naturals, Numinus And Field Trip Discuss Psychedelics At Cantor Webinar

'Sea Change': Irwin Naturals, Numinus And Field Trip Discuss Psychedelics At Cantor Webinar

「海洋變化」:歐文自然,新型和實地考察在坎托爾網絡研討會上討論迷幻藥
Benzinga Real-time News ·  2023/02/03 09:24
Cantor Fitzgerald's Pablo Zuanic hosted a virtual panel discussion about the psychedelics industry with three ketamine therapy providers: Irwin Naturals (OTC:IWINF)' CEO Klee Irwin, Field Trip H&W (OTC:FTHWF)'s co-founder and director Mujeeb Jafferi and Numinus (OTC:NUMIF)' CEO Payton Nyquvest.
康託·菲茨傑拉德的巴勃羅·祖阿尼奇與三家氯胺酮治療提供商共同舉辦了一場關於迷幻藥行業的虛擬小組討論:Irwin Naturals(場外交易代碼:IWINF)的首席執行官Klee Irwin、菲爾德Trip H&W(場外交易代碼:FTHWF)的聯合創始人兼董事的Mujeeb Jafferi and NUMIUS(場外交易代碼:NUMIF)的首席執行官佩頓·尼奎斯特。
See also: These Are The 11 Biggest Psychedelics News And Trends You May Have Missed Last Year
另見:以下是去年你可能錯過預期的11個最大迷幻藥新聞和趨勢
While all three interviewees seem to share similar views on most of the discussed topics, one thing seems certain: the mental health industry is increasingly more open to including PAT within the range of available treatments, as...
雖然三位受訪者似乎在大多數討論的話題上都有相似的觀點,但有一件事似乎是肯定...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論